Nuvectis Pharma, Inc.
NVCT • NASDAQ
Nuvectis Pharma, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Ron Bentsur, with a market cap of $216.2M.
Market Cap$216.2M
Employees13.0
CEORon Bentsur
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 5, 2026 · In 3 weeksQ1 2026
Financials
NVC
Nuvectis Pharma, Inc. FAQ
Common questions about Nuvectis Pharma, Inc.
Nuvectis Pharma, Inc. is scheduled to report earnings for Q1 2026 on May 5, 2026.
Nuvectis Pharma, Inc. has approximately 13 employees.